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ABSTRACT
We study the number of causal variants and asso-
ciated regions identified by top SNPs in rankings
given by the popular 1 df chi-squared statistic,
support vector machine (SVM) and the random
forest (RF) on simulated and real data. If we apply
the SVM and RF to the top 2r chi-square-ranked
SNPs, where r is the number of SNPs with
P-values within the Bonferroni correction, we find
that both improve the ranks of causal variants and
associated regions and achieve higher power on
simulated data. These improvements, however, as
well as stability of the SVM and RF rankings, pro-
gressively decrease as the cutoff increases to 5r
and 10r. As applications we compare the ranks of
previously replicated SNPs in real data, associated
regions in type 1 diabetes, as provided by the Type 1
Diabetes Consortium, and disease risk prediction
accuracies as given by top ranked SNPs by the
three methods. Software and webserver are avail-
able at http://svmsnps.njit.edu.
INTRODUCTION
Genome-wide association studies aim to identify genetic
variants associated with disease, drug response and
various phenotypes (1). The standard method of ranking
SNPs from genome-wide association studies is the one or
two degree of freedom chi-squared test (2).
Previous studies have examined the performance of
the chi-squared statistic in ranking SNPs (3), proposed
techniques to improve the rankings under two-stage
designs (4), and to correct for overestimated signiﬁcance
values and apply the false discovery rate control method
thereafter (5). Other approaches instead of chi-square
have also been proposed for ranking SNPs. These
include the trend test (6), Bayes factors (1), random
forests (RFs) (7–9), support vector machine (SVM; 10),
L1 penalized logistic regression (11,12) and a hidden
Markov model method (13).
Chi-square-based rankings have been found similar to
other univariate tests such as Bayes factors and likelihood
ratios (1,3). Our experiments with information theoretic
methods (14) and the MAX-rank trend test (6) also
show strong similarity to chi-square-based rankings on
simulated data.
In this article, we study the number of causal variants
and associated regions identiﬁed by top SNPs in rankings
given by the popular 1 df chi-squared statistic and two
popular multivariate feature selection methods: the SVM
(15) and the RF method (16). Both have been studied
extensively for the problem of gene selection from micro-
array data (17–20). While the SVM and RF have previ-
ously been applied to genome-wide association studies
(7–10), here we explicitly study their performance in
ranking causal SNPs and those from associated regions
and their performance as a function of the input as ex-
plained below.
We apply each of the two methods to the top kr
chi-square-ranked SNPs where r is the number of SNPs
with P-values at most 0.05 divided by the total number of
SNPs. This corrected P-value threshold is also known as
the Bonferroni correction (21) for multiple hypothesis and
is a common cutoff in genome-wide association studies
(22,23). We show that the SVM(2r) method, which is ba-
sically the SVM method applied to the top 2r chi-square-
ranked SNPs, and RF(2r) contain more causal variants
and those from associated regions compared to chi-square
when we examine the top-ranked SNPs at the Bonferroni
threshold. The SVM performs the best followed by RF
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improvement is less, if at all, in both methods. We also
show that SVM(2r) has the highest power followed by
RF(2r) and chi-square, but this progressively decreases
at the 5r and 10r threshold.
As applications on real data, we show that both
SVM(2r) and RF(2r) improve the ranks of previously
replicated SNPs on Wellcome Trust Case Control
Consortium (WTCCC) (1) genome-wide studies and
identify more known associated type 1 diabetes
regions—as given by the Type 1 Diabetes Consortium
(24)—than chi-square at the Bonferroni cutoff. We also
show that top ranked SVM(2r) SNPs achieve the highest
AUC for type 1 diabetes, arthritis and simulated data
disease risk prediction in testing across independent
cohorts and in cross-validation studies.
In the rest of the article, we provide brief descriptions of
the SVM and RF, followed by the real and simulated data
used in our study. We then present detailed experimental
results including an empirical power study to compare
the three methods followed by results on disease risk pre-
diction. Software and data to reproduce the results in this
article along with a webserver are available at http://
svmsnps.njit.edu.
METHODS
Here, we describe the SVM and RF methods along with
their implementations used in this study. The input to each
method is a case control study with the top kr chi-square-
ranked SNPs where r is the number of SNPs with P-values
within the Bonferroni correction (0.05 divided by total
number of SNPs m) and k is an integer  1. Before
applying each method, we encode each genotype in the
real data as the number of copies of major allele. We
use our own implementation of the one degree of
freedom chi-squared statistic in C which we provide freely.
Support vector machine
The SVM is the optimally separating hyperplane between
two sets of points each belonging to a different class.
The sign of the SVM discriminant w
Tx+w0 determines
the class of input x and the distance to the hyperplane
is given by ðjwTx þ w0jÞ=ðjjwjjÞ (25). The SVM can be rep-
resented by the vector w and scalar w0 that minimizes
ðjjwjj2Þ=ð2ÞþCmaxð0;1   yiðwTxi þ w0ÞÞ where xi is the
genotype vector of the i-th individual, yi is an integer spe-
cifying case (+1) or control ( 1), max(0, 1 yi(w
T xi+w0))
is the hinge loss function, and C is the loss-complexity
tradeoff parameter. The solution w and w0 is obtained
by applying Lagrange multipliers to obtain the dual
problem which is a quadratic program and can be
solved by standard methods see (25,26 for details).
In the SVM, optimization criterion the term
max(0, 1 yi(w
Txi+w0)) measures how well the discrim-
inant w, which is basically our model, ﬁts the training data
and WWwWW
2 measures the complexity of the model. We set the
parameter C to its default value of ð1Þ=ð ijjxijj2Þ, where i
loops over all subjects in the training set, as provided in
the SVM-light software package. We obtain a SNP
ranking from the SVM discriminant w as described below.
Obtaining a SNP ranking from the SVM discriminant
vector w. We can obtain an ordering of the SNPs using
the absolute value of the entries of w. The input to the
discriminant is the set of top mr chi-square ranked SNPs
s1, s2,...smr. The i-th entry of w represents the weight
of the i-th SNP in the input. Let w=(w1,...,wmr) and
WwW=(Ww1W,...,WwmrW). Now consider the entries of WwW in
sorted descending order. We denote this ordering by the
vector p such that jwp1j j wp2j ... j wpmrj. Using p
we obtain an ordering on the input SNP identiﬁers
sp1;sp2;...;spmr which gives us the SNP ranking.
Implementation. We use the popular and freely available
SVM-light SVM implementation (27). We run it with the
linear kernel and all other parameters set to their default
values.
Random forest
A classiﬁcation tree is built by the recursive partitioning
method (25). At each step the feature, which is a SNP in
this study, with the highest impurity, usually measured by
entropy or the Gini index, is selected and then split into k
children where k is the number of values the SNP can take.
This process is repeated until all nodes are pure, meaning
that all sets of decisions leading to that node result in the
same class. In a RF (16), several classiﬁcation trees are
created each by drawing n subjects with replacement
from the original data, where n is the total number of
case and control subjects. The SNPs are then ranked by
a classiﬁcation based variable importance index that
considers interaction between the SNPs (28).
Implementation. We use the freely available willows
software package (28) for generating random forests and
obtaining variable importance indices. We set the number
of trees to 10000 and use the default values for other
parameters as provided by the program.
Datasets
Real data. We use real data from two sources: the
Wellcome Trust Case Control Consortium (WTCCC)
and The Genetics of Kidneys in Diabetes (GoKinD).
The WTCCC provides two sets of controls and one set
of cases each for type 1 diabetes, rheumatoid arthritis,
Crohn’s disease and type 2 diabetes (1) and GoKinD
provides a type 1 diabetes case set (29,30). The WTCCC
also provides case subjects for bipolar disorder, hyperten-
sion and coronary artery disease. However, we omit them
from this study for two reasons. First, much fewer
replicated SNPs are catalogued for them in comparison
to the other four. In Ref. (31), which is from where we
obtain these SNPs, there are just three listed for bipolar,
one for coronary artery disease and none for hyperten-
sion. Second, none of the listed SNPs or those in linkage
disequilibrium with them are captured by twice or even
ﬁve times the number of top chi-square-ranked SNPs
within the Bonferroni correction for bipolar disorder,
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replicated SNP is already ranked as the top one by
chi-square.
We follow the standard protocol of removing
SNPs with >1% missing entries and those that deviate
from Hardy–Weinberg equilibrium with P-values below
5 10
 7 (1). See Supplementary Table S6 for more
details and the number of subjects and SNPs in each
dataset.
Simulated data. The GWAsimulator program (32) pro-
duces case and control genome-wide SNP genotypes
under a logistic regression disease model. It takes as
input a control ﬁle that speciﬁes various parameters such
as relative risk and sample size and phased genotype data,
and simulates SNP genotypes with the same linkage
disequilibrium structure as the input genotype data. It
outputs data in a numerical format as the number of
copies of the causal allele. We use the HapMap CEU
phased genotypes provided with the software package as
input. These genotypes were produced by the Illumina
HumanHap300 SNP chip. The program generates one
causal SNP on a speciﬁed position of a chromosome
and then simulates remaining SNPs according to a
moving window algorithm (33).
We simulated data across several different parameters
from the followings sets of control ﬁles. In each case
though each causal SNP follows a multiplicative model.
This means that if   is the relative risk for one copy of the
risk allele than  
2 is the risk for two copies of that allele.
Except for the power study case we generate one simulated
study per control ﬁle.
. General performance on different relative risks: 50
control ﬁles each for relative risk 1.25, 1.5 and 2.
Each control ﬁle contains 15 randomly selected SNPs
as causal, one per chromosomes 1 through 15 each
with a speciﬁed relative risk. The disease prevalence
is set to .01, and case and control sample sizes each
to 1000. We simulate a 1000 SNPs on either side of
each causal one which adds up to a total of approxi-
mately 30000 SNPs per dataset.
. Performance as a function of sample size: 50 control
ﬁles of relative risk 1.25 and two additional case and
control sizes of 2000 and 4000. Remaining parameters
same as above.
. Performance on low causal allele frequencies: 10
control ﬁles each for relative risk 1.25 and 1.5 and
two case and control sizes of 2000 and 4000, and
causal allele frequencies of at most 5%. Other param-
eters as above in the general performance setting.
. Power study: First ﬁve control ﬁles for relative risks
1.25, 1.5 and 2. We simulated 50 studies for each
control ﬁle thereby giving a total of 250 simulated
studies for each relative risk setting. Remaining par-
ameters same as the general performance setting.
. Disease risk prediction: 50 control ﬁles each for
relative risk 1.25, 1.5 and 2 and same settings as the
general performance case except that 100 case and
100 control subjects are generated instead of 1000
each.
We provide all simulated studies, input control ﬁles and
HapMap CEU phased genotypes to the GWAsimulator
program at http://www.cs.njit.edu/usman/SVMSNPs.
RESULTS
We are interested in measuring the number of causal
variants and associated regions identiﬁed by top SNPs in
a given ranking. In simulated data, we deﬁne an associated
region as the set of SNPs in linkage disequilibrium
(34) with the causal one. In other words, the squared cor-
relation coefﬁcient is at least 0.05, which is a standard
threshold for deﬁning associated regions (12,35). In
order to simulate a scenario where causal variants are
not necessarily genotyped we make a copy of each
simulated study without the causal SNPs and then
compute chi-square, SVM, and random RFs. We also
compute rankings on the original studies with the causal
SNPs.
It is straightforward to measure the number of causal
variants in the number of top-ranked SNPs given by a
method. To measure the number of associated regions
we count the number of unique regions covered by top
ranked SNPs. For example, consider a ranking of ﬁve
SNPs: s1,s2,s3,s4,s5. Suppose that SNPs s1 and s3 belong
to region r1, SNPs s4 and s5 belong to region r2, and the s2
does not belong to any known region. In this ranking, we
have two regions covered by the ﬁve SNPs.
We ﬁrst study the effect of the P-value threshold on the
two methods including both methods applied to all SNPs
in GWAS, effect of sample sizes at relative risk 1.25 and
performance on data with low causal allele frequencies.
We then compare the power of the three methods, their
running times on simulated and real data, and stability of
SNP rankings given by the different methods. Finally, we
study ranks of previously replicated SNPs on real data,
associated regions in type 1 diabetes, and disease risk pre-
diction accuracies of logistic regression as given by top
ranked SNPs by the methods.
Effect of P-value threshold on the support vector
machine and random forest
Let r be the number of SNPs with P-values within the
Bonferroni threshold. We reorder the top 2r,5 r and 10r
chi-square-ranked SNPs with the SVM and RF separately.
At the relative risk 1.25 setting r is 0 for some datasets and
so we exclude them from the analysis.
In Table 1, we show the mean number of causal variants
identiﬁed by the SVM and RF when applied to the top 2r,
5r and 10r chi-square-ranked SNPs as input as well as the
entire GWAS. We examine the top r ranked SNPs in each
method. The larger input to the SVM and RF contains
many more false positives and this clearly deteriorates
their SNP rankings. Similarly, the larger P-value also de-
teriorates the number of associated regions detected by the
two methods as shown in Table 1.
A comparison of the SVM and RF shows that
while SVM(2r) is the best performing method, RF(5r)
and RF(10r) are better than the SVM counterparts.
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associated regions at all three relative risks.
The improvement given by SVM(2r) and RF(2r)i s
small at relative risk 1.25 but increases as we move to
relative risk 1.5 and 2. However, the signal in these
studies depend upon sample size among other things. If
we increase the total sample size to 4000 and 8000 with
each containing half cases and half controls then r, which
is the number of SNPs with P-values within Bonferroni,
increases and so does the improvement given by SVM(2r)
as shown in Table 2 below. In Supplementary Figures
S2–S4, we report mean number of causal variants and
associated regions for different thresholds of top ranked
SNPs instead of the just the top r ranked SNPs. There too
we ﬁnd similar patterns reported here.
The simulated data above has random causal allele
frequencies. In Table 3, we compare the methods on
relative risk 1.25 and 1.5 but with low causal allele
frequencies of at most 5% and with 4000 and 8000
subjects each containing half cases and half controls. We
ﬁnd both SVM(2r) and RF(2r) to perform better than
chi-square at these settings.
We also studied the SVM and RF applied to the entire
GWAS and found that they perform worse than
chi-square and SVM(2r) and RF(2r) (Table 4). Note
that we use the SVM with an automatic setting of the
value of C which controls the tradeoff between error on
training data and model complexity. To be fair to the
SVM we ran it on all the simulated studies of relative
risk 1.5 with ﬁxed values of C from the set {10
 6,1 0
 5,
10
 4,1 0
 3,1 0
 2,1 0
 1}. At C=10
 3 the SVM identiﬁes
the same mean number of causal variants as chi-square
which is 8.9 and at the remaining values it is lower.
Power study
We now compare the empirical power of the chi-square,
SVM and RF to rank causal variants from simulated data
of relative risk 1.5. We deﬁne the empirical power of a
method to be the percentage of simulated datasets where
the top r ranked SNPs given by the method, where r is the
number of SNPs with P-values within Bonferroni correc-
tion, contain k causal variants. In Figure 1, we plot this
value for k ranging from 1 to 15 which is the total number
of causal SNPs in the simulated data. We see that
SVM(2r) has the highest power followed by RF(2r).
In Supplementary Figures S5, we compare the empirical
power of the three methods on simulated data of relative
risk 1.25 and 2. At the 1.25 setting chi-square has highest
power for detecting one causal variant, RF(2r) and
SVM(2r) both have the highest power for detecting two
and three causal variants, and after that all three methods
have same power. At relative risk of 2 all three methods
have the same power up to value of k=12. After that
SVM(2r) has highest power.
Running time comparisons
In Supplementary Tables S1–S3, we show running times
on real data and the simulated one with different relative
risks, sample sizes and causal allele frequency. This
running time includes the time for chi-square since both
methods require a chi-square ranking to start with. These
were measured on AMD Opteron model 2218 machines
each with 2.6GHz speed and 8 GB RAM. Our results
show that running time of all methods depends unsurpris-
ingly on the sample size. However, the running time of
SVM(2r) and RF(2r) also depends on the value of r
which in turn depends on the relative risk and causal
allele frequency. We also see that both RF(2r) and
SVM(2r) are much faster than their 10r counterparts
and the running time for SVM(2r) is comparable to that
of chi-square.
Table 1. Mean number of causal variants and associated regions in
top r SNPs given by each method at the three different relative risks
RR  
2 SV(2r) SV(5r) SV(10r) RF(2r) RF(5r) RF(10r)
Mean number of causal variants
1.25 1.2 1.2 0.9 0.5 1.2 1.1 1
1.5 8.9 10.8 7.4 6.6 9.7 9.3 9.4
2 14 14.6 13.6 13.1 14.1 14.1 13.7
Mean number of associated regions
1.25 1 0.8 0.8 0.8 0.9 0.8 0.8
1.5 4.5 5.9 3.5 2.6 5.3 4.9 4.8
2 10.6 11.9 9.6 9.4 11 10.9 10.8
Table 3. Mean number of causal variants detected in top r ranked
SNPs by each method on data with causal allele frequencies at most
5% and two different sample sizes and relative risks
Sample size and relative risk  
2 SVM(2r) RF(2r)
4000, 1.25 0.5 1 1
8000, 1.25 1.7 2.5 2.5
4000, 1.5 4.8 6.3 6.1
8000, 1.5 12.7 13.2 13.3
Table 4. Mean number of causal variants and associated regions in
SVM and RF applied to all SNPs in the GWAS
RR Causal variants Associated regions
 
2 SVM RF  
2 SVM RF
1.25 1.2 1.3 1 1 0.8 0.9
1.5 8.9 8.1 8.7 4.8 4.3 4.8
2 14 12.4 14 10.6 9.4 10.7
Table 2. Mean number of causal variants detected in top r ranked
SNPs given by each method on different sample sizes at relative
risk 1.25
Sample size Mean r  
2 SVM(2r) RF(2r)
2000 2.1 1.2 1.2 1.2
4000 9.2 4.8 5.7 4.4
8000 31.7 11.0 12.1 8.5
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In line with recent studies that examine stability of ranked
gene and SNP lists, we do the same for the SVM and RF
methods on our simulated data (36,37). Following these
studies we create a jacknifed dataset by randomly
removing 10% of the subjects from a given simulated
study. In this manner, we create 100 jacknifed studies
and compute chi-square, SVM and RF rankings with
the four P-value thresholds of r,2 r,5 r and 10r on each
one. As before r denotes the number of SNPs with
P-values within the Bonferroni correction. We perform
this on process on simulated studies one through ﬁve.
For each of the three methods we then compute the cor-
relation coefﬁcient between the ranks of the top r SNPs
captured by chi-square on the original datasets with their
mean rank in the jacknifed studies.
We study two variants of the random forest method.
In RF(100), we set the number of trees in the forest to
100 and in RF(10000) we set this to 10000. Note that the
latter setting is the one we used in the experiments
throughout this paper. In Table 5, we see that the correl-
ation is high at the r threshold for all methods but pro-
gressively decreases as the P-value threshold increases. We
also ﬁnd that the random forest with 10000 trees has
much better stability than with just 100 trees even
though the former has a higher running time.
Calle et al. (36) report a low correlation when they study
the stability of the RF applied to all SNPs in a real study.
In agreement with their results, we ﬁnd that the correl-
ation of RF(100) and RF(10000) are both very low
when applied to the entire GWAS. In Supplementary
Tables S4 and S5, we show the stability at relative risk
1.25 and 2. There too we ﬁnd high stability at the r and
2r thresholds and RF(10000) doing much better than
RF(100).
Applications on real data
We demonstrate some applications of our work by
studying ranks of previously replicated SNPs, associated
regions in type 1 diabetes and prediction of disease risk as
given by top-ranked SNPs by the three methods.
Ranks of previously replicated SNPs in WTCCC
studies. The Bonferroni corrections r for the WTCCC
type 1 diabetes, arthritis, Crohn’s disease and type 2
diabetes are 452, 176, 63 and 14, respectively. We
compute SVM and RF rankings with the three thresholds
and show results in Supplementary Tables S7 and S8. In
type 1 diabetes and arthritis, we see a clear improvement
in rank by SVM(2r) and a less pronounced one by RF(2r).
As the threshold increases from 2r to 5r and 10r the
ranking given by SVM and RF deteriorates. In Crohn’s
disease and type 2 diabetes the rankings are comparable.
Note that the value of r for these two diseases is also much
smaller than the ones for the other two.
Type 1 diabetes-associated regions. As in the simulated
data, we deﬁne an associated region for each replicated
as the set of all SNPs with squared correlation coefﬁcient
at least 0.05 with the replicated SNP. We also examine
associated regions deﬁned by the Type 1 Diabetes
Consortium (24) and list SNPs and boundaries of both
sets of regions in Section 8 of the Supplementary Data.
We consider a region as detected if the top r SNPs of a
ranking contains at least one SNP from the region. The
Bonferroni corrected P-value threshold is about 10
 7
which yields 452 SNPs. If we double this to 904 SNPs
the P-value threshold increases to about 0.002 and
includes many more regions not detected by chi-square.
Table 6 shows that the SVM(2r) and RF(2r) can lift the
ranks of many SNPs from these undetected regions to
above 452.
Prediction of type 1 diabetes risk on independent
studies. The previous few sections have demonstrated
that the SVM(2r) and RF(2r) can lift the ranks of causal
SNPs and those from associated regions compared to
chi-square on simulated data. We expect that top ranked
SNPs given by the SVM should be enough for predicting
disease risk accurately since they are mostly causal and
cover several associated regions. To test this hypothesis,
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Figure 1. Empirical power to detect k causal variants in simulated data
of relative risk 1.5.
Table 6. Number of type 1 diabetes associated regions given by
top r SNPs of chi-square, RF(2r) and SVM(2r)
Regions deﬁned by
replicated SNPs in Ref. (31)
T1D Base
regions
 
2 55
RF(2r)8 1 3
SVM(2r)9 1 5
Table 5. Correlation coefﬁcient between original SNP ranks and
mean SNP ranks across 100 jacknifed datasets of relative risk 1.5
r 2r 5r 10r
 
2 0.99 0.99 0.97 0.94
SVM 0.99 0.98 0.97 0.96
RF(100) 0.87 0.84 0.65 0.59
RF(10000) 0.99 0.98 0.95 0.91
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sion based} composite odds ratio score (31,38,39) for pre-
dicting type 1 diabetes risk as a function of top-ranked
SNPs given by the three methods including chi-square. See
the Supplementary Data for details of the composite odds
ratio score (Section 1), cross-validation results on the
WTCCC arthritis study (Supplementary Figures S9) and
risk prediction on simulated data with this risk estimator
(Supplementary Figures S10 and S11).
We compute SNPs rankings on the WTCCC study and
then classify subjects in the GoKinD study plus WTCCC
coronary artery disease samples as controls using top
ranked SNPs from the three different methods. We also
repeat these steps by computing SNP rankings on the
GoKinD study and predicting on the WTCCC one. In
Figure 2, we show the composite odds ratio AUC as a
function of top ranked SNPs in the three rankings.
SVM(r) achieves the highest AUC of 0.83 with 21 SNPs
followed by random forest and chi-square AUCs of 0.81
each with 29 and 17 SNPs, respectively. See Supplemen-
tary Figure S8 for graphs comparing AUCs of the SVM
score for predicting disease risk (40).
We make similar observations if we compute the
rankings on the GoKinD study and predict risk on the
WTCCC study. Figure 2 and its reverse counterpart in
Supplementary Figure S7 show that many initial thresh-
olds of top SVM-ranked SNPs are consistent in their pre-
diction AUC. With chi-square the AUC is highest for a
few top ranked SNPs after which it begins to fall quickly.
In fact, this also happens for arthritis as shown in
Supplementary Figure S9. The rapid drop in type 1
diabetes and arthritis prediction with chi-square-ranked
SNPs is also observed by Evans et al. (31) who use a com-
posite odds ratio score similar to ours.
DISCUSSION
The work presented here sheds light into the performance
of the SVM and the RF method for ranking SNPs in
genome-wide association studies. As the P-value threshold
increases the ranking of causal SNPs and those from
associated regions deteriorates by each method suggesting
that non-causal SNPs and those not from associated
regions affect the performance of these two discriminative
multivariate methods.
In unpublished work, we make similar observations with
three other multivariate feature selection methods: L2
norm regularized logistic regression (41), the weighted
maximum margin criterion (42) and ridge regression
(25). We use the Bundle software package (41) for
regularized logistic regression and our own implementa-
tions of the latter two methods. After cross-validating par-
ameters in each method, we ﬁnd that at the 2r threshold
level all methods improve upon chi-square to different
degrees but the improvement decreases at higher thresh-
olds.
The strategy of removing features in high-dimensional
data using a simple statistic before applying a more
sophisticated method has been studied previously but
not exactly in the manner that we do and not on
genome-wide studies. Take the winners of the NIPS
2003 feature selection contest. They used a simple
univariate statistic to obtain a smaller input size before
applying a more sophisticated neural network plus
tree-based multivariate procedure for ﬁnal feature selec-
tion (43). Fan and Lv (44) provide theoretical and empir-
ical arguments for the same idea: removing many features
with a simple statistic before applying a sophisticated
multivariate one for ﬁnal selection. Finally, Chen and
Lin (45) show that removing features with a simple
univariate ‘F-score’ statistic improves classiﬁcation per-
formance of the SVM on all but one of the datasets
used in the NIPS 2003 contest. This is not the same as
SVM-based feature selection but is relevant to our work
because it says something about SVM discriminant
computed with full versus a culled set of features.
The SVM has previously been shown to rank
non-causal variables higher than causal ones empirically
(46) and theoretically (47). In both studies, culling the
input dataset by a univariate ﬁlter was not considered.
In light of our results here and the studies cited above it
is possible that the SVM may yield better results in those
studies if the input is ﬁrst culled.
When the SVM is applied to the entire GWAS we ﬁnd
its ranking of causal variants and associated regions to be
similar to chi-square and better than SVM(5r) and
SVM(10r). This can be explained by the automatic
setting of the SVM loss-complexity tradeoff parameter
C ¼ 1
 ijjxijj2, where i loops over all subjects in the training
set. When the entire GWAS is considered each WWxiWW
2 is large
which makes C a very small number particularly in com-
parison to the value obtained in SVM(5r) and SVM(10r).
This affects the discriminant w which is actually given by
w=
P
i ai yi xi where each ai C (25), yi is+1 if xi is case
and  1 otherwise. With a very small value of C all of ai
are small and the same thus effectively reducing the dis-
criminant value of the j-th SNP to be
Pn 1
i¼0 yixij where n is
the total number of subjects in the study, yi as deﬁned
above, and xij is the j-th encoded SNP of the i-th
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 0.78
 0.8
 0.82
 0.84
0 50 100 150 200 250 300 350
A
U
C
Number of top ranked SNPs 
Chi-square
RF(r)
SVM(r)
Figure 2. ROC area under curve of the composite odds ratio score on
the GoKinD type 1 diabetes study as a function of top-ranked SNPs
obtained from the WTCCC study by the three different methods.
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number zero and ﬁnd the SVM ranking to be similar to
the one obtained using the above formula.
It is important to note that our work with the SVM
presented here does not cross-validate the tuning param-
eter C which controls tradeoff between error on the
training data and the classiﬁer complexity. As mentioned
earlier, we use a default value of C provided by the
SVM-light software. We did perform the same experi-
ments by cross-validating C and found no difference in
the performance of the support vector machine at the 2r
threshold. At the larger 5r and 10r thresholds the SVM
performs better with the cross-validated C than the auto-
matic one. The improvement, however, is not large
enough to justify an expensive cross-validation procedure
which is why we omit the procedure from this study
altogether.
The less pronounced differences between the multivari-
ate methods and chi-square on the WTCCC Crohn’s
disease and type 2 diabetes studies as well as on simulated
data of relative risk 1.25 suggest that the advantage from
multivariate methods over univariate in genome-wide
studies may be gained only on studies where the value of
r, which is the number of SNPs with P-values within
Bonferroni, is non-trivial. This becomes clear if we
compare the values of r across the three different
relative risks at ﬁxed sample sizes of 2000 and across the
different sample sizes at relative risk 1.25.
Our risk prediction results show limited improvement
with SVM-ranked SNPs compared to chi-square and RF
ones. However, there are several aspects of this improve-
ment that are noteworthy: (i) we see it consistently on
many simulated datasets, (ii) it becomes larger at higher
relative risks, and (iii) the AUC peaks earlier with a few
top SVM ranked SNPs when compared to the chi-square
ranked ones. In Supplementary Figures S10 and S11, we
provide risk prediction results on simulated data that
support the above observations. There we see that the
improvement given by a few top SVM-ranked SNPs is
highest at relative risk 2 and progressively decreases at
lower relative risks. This suggests that there is a potential
to gain higher risk prediction accuracy with SVM ranked
SNPs if there is sufﬁcient signal in a GWAS. This may
very well be the case with GWAS that have larger sample
sizes and more SNPs than current ones. It is part of our
ongoing research to test these methods on such GWAS.
Although we have not explored this in detail here, the
SVM(2r) and RF(2r) methods both have the potential to
detect interacting SNPs. A straightforward, yet computa-
tionally expensive, solution would be to ﬁrst recode all
pairs of SNPs into new numerical values between 0 and
8 instead of encoding each SNP 0, 1 or 2. Then we would
apply SVM(2r) and RF(2r) in the same way as done in
this article and examine the top r ranked variables for
interacting SNPs.
We also rank all SNPs in the GWAS by the SVM and
apply chi-square to the top 100 ranked ones to determine
if it would improve upon the support vector machine
ranking. Supplementary Figures S6 shows that this
offers no improvement over chi-square applied to the
entire GWAS.
Finally, it is straightforward to incorporate non-genetic
variables such as age, sex and principal components for
population substructure into the SVM(kr) and RF(kr)
methods. They would simply be additional columns in
the culled data matrix that is given as input.
CONCLUSION
We ﬁnd the support vector machine to rank causal
SNPs and those from associated regions higher than
random forest and chi-square if applied to the top 2r
chi-square-ranked SNPs, where r is the number of SNPs
with p-values within Bonferroni, and the value of r is suf-
ﬁciently large.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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